Applying Six-Sigma Tools and Concepts in Clinical Research – A Process Improvement Guide0 Available
Six Sigma is a well-known certification within the manufacturing world, but it’s concepts and practices that can easily be applied to routine activities in clinical research. This course will introduce you to several tools that have been recognized in Six Sigma certification training. The curriculum will demonstrate how simplified, modified versions of these tools are already in use, and guide you on identification and use. Upon completion, you will have actionable, practical Six Sigma tools to bring to bear on your clinical operations – from Sponsor to Site.
Blockchain Technology for the Life Sciences: A Comprehensive Primer0 Available
This course will explore areas within the life sciences where early adoption is a possibility. A vendor-neutral review of current Blockchain software platforms and their potential fit within your organization will be provided. Finally, you will receive instruction on how to identify and execute the steps necessary for determining if Blockchain is applicable to your function within your organization.
Clinical Quality Management Systems (QMS): Establishing A Practical & Compliant Program0 Available
Many small to mid-sized biotech and pharmaceutical companies possess exciting science, promising products, and endless opportunity. However, most lack the kind of robust clinical Quality Management Systems (QMS) required by global health authorities. Since patients and profits are at risk, it is critical to establish these systems for market approval and patient safety. This course will give you the necessary tools to establish a working and compliant QMS for your business.
Clinical Research Project Management – 7 Breakthrough Behaviors For Success0 Available
Clinical project management is a marathon…not a sprint. However, the road isn’t always flat. Distractions, obstacles, pitfalls, and budget overruns can thwart even the best project manager. However, seven simple behaviors can eliminate this problem. This session will outline these behaviors, why they are critical, and help you implement them to ensure the efficiency and efficacy of your clinical trials.
Critical Thinking In Clinical Research – A Better Wayhot
Attend this live webinar, to learn from recognized industry experts about the DIGR-ACT® Solution – an exciting methodology for supporting critical thinking in risks and issues management specifically designed for the clinical trial professional.
Essentials of Disinfectant Efficacy Testing – Ensuring Microbial Control0 Available
Disinfectant efficacy testing is utilized to measure the effectiveness of chemicals that are used clean, sanitize, or disinfect surfaces. Understanding the importance of testing and proper use of disinfectants is essential in avoiding regulatory findings. This webinar will review the essentials of disinfectant efficacy testing.
Identifying Workforce Gaps Post Risk-Based Monitoring (RBM): It’s Time to “DIG” in!0 Available
Risk-based Monitoring (RBM) is a practice embraced by industry and global Health Authorities. Educating and supporting current resources is a significant challenge for sponsors/CROs and investigation sites and has been a root cause of weak ineffective study start-up efforts. This course will help you train staff to ensure robust RBM activities and ensure success.
Implementing a Robust Change Control Program – Key Elements for Process and Documentation Compliance0 Available
Change control is a critical piece of any life sciences activity…and a global regulatory requirement. Change control deficiencies are mentioned directly or indirectly in most inspection observation findings. Compliance is a must, and a business imperative. This course will help you get on the right track with your change control programs, documentation, and overall compliance.
New FDA Draft Guidance – A Risk-Based Approach to Monitoring of Clinical Investigations0 Available
In March 2019, FDA released a new draft guidance titled “A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers” which helps support the 2013 “Oversight of Clinical Investigations – A Risk-Based Approach to Monitoring” (RBM) guidance. This new draft guidance is currently open for comment and further underscores FDA’s emphasis on clinical studies being overseen using risk-based techniques. This session will illuminate FDA’s thinking and help you prepare.